Wei Zhang
Presidente presso CASI PHARMACEUTICALS, INC.
Patrimonio netto: 11 083 $ in data 30/06/2024
Profilo
Dr. Wei Zhang is a Global President at CASI Pharmaceuticals, Inc. Dr. Zhang was previously employed as a President by Casi Beijing Pharmaceuticals Co. Ltd., a President by CASI Pharmaceuticals, Inc. /Old/, a Chief Executive Officer by Sandoz (China) Pharmaceutical Co., Ltd., and a VP, Head-Public Affairs & Corporate Responsibility by Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
He received his undergraduate degree from the University of Science & Technology of China, a graduate degree from the University of Science & Technology of China, an MBA from the University of California, Los Angeles and a doctorate degree from the University of Utah.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/03/2024 | 2 015 ( 0.02% ) | 11 083 $ | 30/06/2024 |
Posizioni attive di Wei Zhang
| Società | Posizione | Inizio |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Presidente | 01/09/2019 |
Precedenti posizioni note di Wei Zhang
| Società | Posizione | Fine |
|---|---|---|
Casi Beijing Pharmaceuticals Co. Ltd.
 Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | Presidente | 01/09/2019 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Amministratore Delegato | 01/01/2016 |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Corporate Officer/Principal | - |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Direttore Finanziario/CFO | 16/12/2020 |
Formazione di Wei Zhang
| University of Science & Technology of China | Graduate Degree |
| University of California, Los Angeles | Masters Business Admin |
| University of Utah | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Casi Beijing Pharmaceuticals Co. Ltd.
Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Health Technology |
- Borsa valori
- Insiders
- Wei Zhang
